Details for New Drug Application (NDA): 080044
✉ Email this page to a colleague
NDA 080044 describes PROPOXYPHENE COMPOUND 65, which is a drug marketed by Ivax Sub Teva Pharms, Sandoz, and Teva, and is included in three NDAs. Additional details are available on the PROPOXYPHENE COMPOUND 65 profile page.
The generic ingredient in PROPOXYPHENE COMPOUND 65 is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.
The generic ingredient in PROPOXYPHENE COMPOUND 65 is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.
Summary for 080044
| Tradename: | PROPOXYPHENE COMPOUND 65 |
| Applicant: | Sandoz |
| Ingredient: | aspirin; caffeine; propoxyphene hydrochloride |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 389MG;32.4MG;65MG | ||||
| Approval Date: | Sep 16, 1983 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
